Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Merck
Colorcon
Harvard Business School
AstraZeneca

Last Updated: September 26, 2022

Enflurane - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for enflurane and what is the scope of patent protection?

Enflurane is the generic ingredient in two branded drugs marketed by Abbott, Piramal Critical, and Baxter Hlthcare, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for enflurane.

Recent Clinical Trials for enflurane

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Penn State UniversityPhase 4
University of LeipzigPhase 4
RWTH Aachen UniversityPhase 4

See all enflurane clinical trials

Medical Subject Heading (MeSH) Categories for enflurane
Anatomical Therapeutic Chemical (ATC) Classes for enflurane

US Patents and Regulatory Information for enflurane

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott ENFLURANE enflurane LIQUID;INHALATION 070803-001 Sep 8, 1987 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Baxter Hlthcare ETHRANE enflurane LIQUID;INHALATION 017087-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Piramal Critical ENFLURANE enflurane LIQUID;INHALATION 074396-001 Jul 29, 1994 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for enflurane

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare ETHRANE enflurane LIQUID;INHALATION 017087-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Baxter Hlthcare ETHRANE enflurane LIQUID;INHALATION 017087-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
AstraZeneca
Baxter
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.